DOI: 10.1128/CVI.00165-17
Article Information
PubMed
Published By
History
- Received June 2, 2017
- Returned for modification June 29, 2017
- Accepted August 28, 2017
- Published online November 6, 2017.
Copyright & Usage
Copyright © 2017 American Society for Microbiology.
All Rights Reserved
.
Editors and / or Reviewers
- Drusilla L. Burns, Editor, Food and Drug Administration
Article Versions
- Accepted Manuscript version (September 06, 2017).
- You are viewing the most recent version of this article.
Author Information
- Eric K. Dumasa,b,
- Timothy Grossa,
- Jason Larabeeb,
- Lance Patea,
- Hannah Cuthbertsonc,
- Sue Charltonc,
- Bassam Hallisc,
- Renata J. M. Englerd,
- Limone C. Collins Jr.d,
- Christina E. Spoonerd,
- Hua Chena,
- Jimmy Ballardb,
- Judith A. Jamesa,e and
- A. Darise Farrisa,b
- aArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation (OMRF), Oklahoma City, Oklahoma, USA
- bDepartment of Microbiology and Immunology, University of Oklahoma Health Sciences Center (OUHSC), Oklahoma City, Oklahoma, USA
- cPublic Health England, National Infection Service, Porton Down, Salisbury, United Kingdom
- dWalter Reed National Military Medical Center, Bethesda, Maryland, USA
- eDepartments of Medicine and Pathology, OUHSC, Oklahoma City, Oklahoma, USA
- Address correspondence to A. Darise Farris, darise-farris{at}omrf.org.
Citation Dumas EK, Gross T, Larabee J, Pate L, Cuthbertson H, Charlton S, Hallis B, Engler RJM, Collins LC, Jr, Spooner CE, Chen H, Ballard J, James JA, Farris AD. 2017. Anthrax vaccine precipitated induces edema toxin-neutralizing, edema factor-specific antibodies in human recipients. Clin Vaccine Immunol 24:e00165-17. https://doi.org/10.1128/CVI.00165-17 .
Article usage
Anthrax Vaccine Precipitated Induces Edema Toxin-Neutralizing, Edema Factor-Specific Antibodies in Human Recipients
